Scarica l'app Stockscreener
1.09
4.39%
-0.05
Precedente Chiudi:
$1.14
Aprire:
$1.14
Volume 24 ore:
701.97K
Relative Volume:
2.36
Capitalizzazione di mercato:
$100.15M
Reddito:
-
Utile/perdita netta:
$-30.15M
Rapporto P/E:
-1.1978
EPS:
-0.91
Flusso di cassa netto:
$-31.63M
1 W Prestazione:
-6.03%
1M Prestazione:
-14.17%
6M Prestazione:
+57.74%
1 anno Prestazione:
-27.33%
Intervallo 1D:
$0.9999
$1.14
Intervallo di 1 settimana:
$0.9999
$1.255
Portata 52W:
$0.49
$1.65
Context Therapeutics Inc Stock (CNTX) Company Profile
Nome
Context Therapeutics Inc
Settore
Industria
Telefono
267-225-7416
Indirizzo
2001 MARKET STREET, PHILADELPHIA
Confronta CNTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNTX
Context Therapeutics Inc
|
1.09 | 104.74M | 0 | -30.15M | -31.63M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Context Therapeutics Inc Stock (CNTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-18 | Iniziato | Guggenheim | Buy |
| 2025-04-21 | Iniziato | William Blair | Outperform |
| 2025-01-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-11-25 | Iniziato | D. Boral Capital | Buy |
| 2024-05-16 | Iniziato | Piper Sandler | Overweight |
Context Therapeutics Inc Borsa (CNTX) Ultime notizie
Context Therapeutics (NASDAQ:CNTX) Upgraded to “Sell” at Wall Street Zen - Defense World
What drives Context Therapeutics Inc stock priceTrading Volume Trends & Affordable Growth Strategies - earlytimes.in
What technical charts say about Context Therapeutics Inc. stockWeekly Stock Analysis & Free Fast Gain Swing Trade Alerts - newser.com
Why analysts remain bullish on Context Therapeutics Inc. stockSwing Trade & Accurate Intraday Trading Signals - newser.com
Is Context Therapeutics Inc. stock a safe buy before earnings2025 Performance Recap & Technical Entry and Exit Alerts - newser.com
Is Context Therapeutics Inc. stock poised for growthJuly 2025 Decliners & Long-Term Growth Plans - newser.com
Using portfolio simulators with Context Therapeutics Inc. includedMarket Growth Report & Long-Term Capital Growth Ideas - newser.com
Published on: 2025-11-16 17:23:15 - newser.com
What’s the recovery path for long term holders of Context Therapeutics Inc.Market Risk Report & Daily Stock Momentum Reports - newser.com
Is Context Therapeutics Inc. stock resilient to inflationJuly 2025 Snapshot & Fast Moving Stock Watchlists - newser.com
Published on: 2025-11-15 13:42:26 - newser.com
Exit strategy if you’re trapped in Context Therapeutics Inc.July 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
Is Context Therapeutics Inc. stock a top pick in earnings seasonJuly 2025 Trade Ideas & Smart Money Movement Alerts - newser.com
Is Context Therapeutics Inc. stock positioned well for digital economyGlobal Markets & Risk Controlled Daily Plans - newser.com
How institutional buying supports Context Therapeutics Inc. stockAnalyst Downgrade & Stepwise Trade Signal Guides - Fundação Cultural do Pará
Does Context Therapeutics Inc. stock trade at a discount to peers2025 Dividend Review & Verified Entry Point Detection - newser.com
Context Therapeutics Reports Encouraging Early Data in Cancer Trials, Eyes 2026 Milestones - MyChesCo
Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting - Black Hills Pioneer
Is Context Therapeutics Inc. stock a defensive play in 2025July 2025 Reactions & Daily Profit Focused Screening - newser.com
Private equity firms who hold 46% of Context Therapeutics Inc. (NASDAQ:CNTX) gained 11%, institutions profited as well - simplywall.st
Context Therapeutics Inc. stock trendline breakdownSwing Trade & Stock Market Timing Techniques - newser.com
Cantor Fitzgerald Has Weak Estimate for CNTX FY2025 Earnings - Defense World
Published on: 2025-11-10 05:16:01 - newser.com
Context Therapeutics Inc Azioni (CNTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Context Therapeutics Inc Azioni (CNTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Levit Alex C. | Chief Legal Officer, Corp. Sec |
Jun 06 '25 |
Buy |
0.58 |
20,000 |
11,520 |
29,000 |
| Minai-Azary Jennifer Lynn | Chief Financial Officer |
Jun 06 '25 |
Buy |
0.64 |
40,010 |
25,486 |
80,010 |
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):